http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2200991-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-017
filingDate 1995-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7743c30eddc974a48500a9b9e0b74f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fa8a2a86a987596e15299a915b0b283
publicationDate 1996-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2200991-A1
titleOfInvention Compounds for the suppression of hiv tat transactivation
abstract The present invention reveals the isolation, purification and characterization from the creosote bush Larrea tridentata of compounds of structural formula (I) where R1, R2, R3 and R4 are each selected from the group consisting of HO-, CH3O- and CH3(C=O)O-, provided that R1, R2, R3 and R4 are not each HO- simultaneously. Each compound is a derivative of 1,4-bis-(3,4-dihydroxyphenyl)-2, 3--dimethylbutane (nordihydroquaiaretic acid, NDGA). In addition, NDGA and each derivative can be used in a method to suppress Tat transactivation of a lentivirus, including the HIV virus, in a cell by administering NDGA or a derivative of NDGA to the cell.
priorityDate 1994-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4534
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526473
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID66636
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID66636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501887

Total number of triples: 38.